Skip to main content
HR 148 116th Congress House

Byron Nash Renal Medullary Carcinoma Awareness Act of 2019

Official title: To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving med… Show full official titleShow less

Official title: To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have Sickle Cell Disease.

Introduced: August 6, 2019 Introduced by: Green, Al Democratic · Texas See on congress.gov
Health CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 25, 2019
Referred to the Subcommittee on Health.
Jan 3, 2019
Referred to the House Committee on Energy and Commerce.
Jan 3, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action January 25, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Byron Nash Renal Medullary Carcinoma Awareness Act of 2019

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1
D
Veasey, Marc A.
Texas · Aug 6, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 148: Byron Nash Renal Medullary Carcinoma Awareness Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-148/
MLA
"H.R. 148: Byron Nash Renal Medullary Carcinoma Awareness Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-148/.
Bluebook (legal)
H.R. 148, 116th Cong. (2026), https://openamerica.io/bill/116-HR-148/.
Markdown link
[H.R. 148: Byron Nash Renal Medullary Carcinoma Awareness Act of 2019](https://openamerica.io/bill/116-HR-148/)
Report a problem